Suggested Dosing
Syrup
adult: 15 mL (1 tablespoon) PO QID x3-5day (Sambucol, Nature's Way)
children: 15 mL (1 tablespoon) PO BID x3day
Lozenge
175 mg PO QID x2d
Topical
leaves are used for bruises, sprains, wounds, & burns
Other Information
Elderberry daily value not established, see individual product
Elderberry should be started within 24-28 hours of symptom onset.
Suggested Uses
Treatment & Prevention of
common cold, cough & flu symptoms, sinusitis, immunostimulant, mouth ulcers, tonsillitis
Elderberry Extract
reduces damaging effects of LDL & protects as an antioxidant
Leaves, Topical Application
Treatment of bruises, sprains, wounds, burns & chilblains, mouthwash for mouth ulcers
Tincture
Rheumatic conditions
Oil
Painful joints
Efficacy
Demonstrated effective in symptom reduction and prophylaxis of cold, flu, URI
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (25)
- acarbose
elderberry increases effects of acarbose by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- chlorpropamide
elderberry increases effects of chlorpropamide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- glimepiride
elderberry increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- glipizide
elderberry increases effects of glipizide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- glyburide
elderberry increases effects of glyburide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin aspart
elderberry increases effects of insulin aspart by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin detemir
elderberry increases effects of insulin detemir by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin glargine
elderberry increases effects of insulin glargine by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin glulisine
elderberry increases effects of insulin glulisine by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin lispro
elderberry increases effects of insulin lispro by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin NPH
elderberry increases effects of insulin NPH by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- insulin regular human
elderberry increases effects of insulin regular human by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- metformin
elderberry increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- miglitol
elderberry increases effects of miglitol by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- nateglinide
elderberry increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- pioglitazone
elderberry increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- repaglinide
elderberry increases effects of repaglinide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- rosiglitazone
elderberry increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- saxagliptin
elderberry increases effects of saxagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- sitagliptin
elderberry increases effects of sitagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- theophylline
elderberry increases effects of theophylline by decreasing metabolism. Minor/Significance Unknown.
- tolazamide
elderberry increases effects of tolazamide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- tolbutamide
elderberry increases effects of tolbutamide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
- treosulfan
elderberry increases effects of treosulfan by pharmacodynamic synergism. Minor/Significance Unknown.
- vildagliptin
elderberry increases effects of vildagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).
Adverse Effects
Frequency Not Defined
Nausea/vomiting (consumption of raw berries)
Warnings
Contraindications
Consumption of all green plant parts
Cautions
Do not eat raw: mild cyanide toxicity is destroyed by cooking
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Antioxidant: free radical protection; anthocyanin protection against cellular aging
Flavonoids: therapeutic activity
Elderberry extract: reduces damaging effects of LDL cholesterol
Efficacy
- Treatment & reduction of symptoms & prophylaxis of cold, flu, cough & mouth ulcers
